The Wegovy 2.4 mg clicks chart: what the numbers actually mean

The biggest misconception: clicks let you control your dose

The most common reason people search for a Wegovy 2.4 mg clicks chart is the belief that counting clicks is how you dial in or verify a specific dose amount. That's not how these pens work. Unlike insulin pens with a variable dial, Wegovy comes in individual pre-filled pens, each loaded at the factory with one dose and one dose only. You cannot increase, decrease or split it by stopping early or pressing harder.

What the clicks do is signal injection progress. As the plunger travels, audible or tactile clicks indicate that the mechanism is moving. A specific total click count, as detailed in the Wegovy Patient Information Leaflet on the eMC, tells you the injection is finished. Stopping before that count means some medicine may remain in the pen, not that you've taken a smaller dose on purpose.

Holding the pen firmly against the skin for the full duration specified in the leaflet is the practical detail that trips most people up. Our prescribers hear this question regularly: a partial click count almost always traces back to lifting the pen too soon, not a fault with the medicine. Check the leaflet first; if you're still uncertain, contact your prescribing team before your next dose.

How the 2.4 mg dose fits into the titration journey

Reaching the 2.4 mg maintenance dose is a gradual process. The semaglutide titration schedule starts at 0.25 mg weekly, stepping up approximately every four weeks through 0.5 mg, 1.0 mg and 1.7 mg before arriving at 2.4 mg, which has its own distinct pen and click pattern compared with every earlier strength. Each strength uses its own pen with its own delivery mechanism, so the click pattern for a 1.7 mg pen is not the same as for a 2.4 mg one. You can read more about how the full dose range is structured on the Wegovy doses overview page.

This staged approach exists because the most common side effects of semaglutide (nausea, loose stools, burping, and fatigue) are most pronounced when the dose first rises. Slow titration keeps those effects manageable for most people. Clinical trials underpinning the 2.4 mg licence, including the STEP 1 study published in the New England Journal of Medicine, used this same schedule to achieve an average weight reduction of around 15% over 68 weeks.

Your prescriber sets the pace. If a step causes persistent symptoms, the schedule may be paused or repeated, that clinical judgement belongs with the prescriber, not a chart.

What the clicks chart is genuinely useful for

A properly sourced Wegovy 2.4 mg clicks dosage chart, such as the one included with the manufacturer's patient materials or reproduced in the NHS guidance on semaglutide, gives you a simple cross-reference: number of clicks heard equals dose delivered, yes or no. For many patients, particularly those with hearing or dexterity differences, having that count written down is genuinely practical rather than just reassuring.

What a chart cannot do is replace the full technique guidance in your Patient Information Leaflet: needle attachment, skin pinch, injection site rotation across the abdomen, thigh or upper arm, and the post-injection hold time. These steps together determine whether the dose is absorbed as intended. Pen storage matters too, Wegovy should be kept refrigerated between 2°C and 8°C; the leaflet states how long it may remain at room temperature, and if your pen has been sitting in a gym bag through a summer afternoon, checking those limits before injecting is worth a moment of your time.

There are several detailed resources on injection technique and related topics, including a dosage chart guide and a breakdown of the 2.4 click chart specifically, that go deeper into the mechanics if you want them.

When to ask your prescriber, not a chart

A chart covers normal use. It does not cover what to do if you pressed the plunger but heard no click at all, if the window shows medicine remaining after you felt the end-of-dose indicator, or if the pen appears damaged. Those are prescriber and pharmacist questions, not search queries.

Similarly, questions about whether 2.4 mg is the right target for you, whether a slower titration would suit you better, or how to interpret your progress sit firmly with your clinical team. If you're exploring whether Wegovy could be appropriate for your circumstances, the weight-loss treatment overview explains the licensed eligibility criteria and how assessment works. For a broader look at what Wegovy involves as a treatment, the Wegovy information page covers the mechanism, the evidence and what private access looks like.

On the question of cost, the Wegovy price comparison page sets out what private treatment typically costs in the UK and what a legitimate price should include. Treatment pricing varies by dose and provider; any quote that omits consultation, prescription and clinical review is only showing part of the picture.

If you're ready to discuss whether semaglutide is clinically appropriate for you, start your free consultation and a GPhC-registered Independent Prescriber will review your answers the same day.